company background image
1SAN logo

Sanofi BIT:1SAN Stock Report

Last Price

€91.00

Market Cap

€114.6b

7D

3.9%

1Y

-9.8%

Updated

27 Mar, 2024

Data

Company Financials +

1SAN Stock Overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

1SAN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Sanofi Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi
Historical stock prices
Current Share Price€91.00
52 Week High€105.00
52 Week Low€80.75
Beta0.44
1 Month Change1.76%
3 Month Change1.76%
1 Year Change-9.79%
3 Year Change7.95%
5 Year Change16.52%
Change since IPO15.19%

Recent News & Updates

Recent updates

Shareholder Returns

1SANIT PharmaceuticalsIT Market
7D3.9%0.7%1.3%
1Y-9.8%12.3%25.2%

Return vs Industry: 1SAN underperformed the Italian Pharmaceuticals industry which returned 12.6% over the past year.

Return vs Market: 1SAN underperformed the Italian Market which returned 26.4% over the past year.

Price Volatility

Is 1SAN's price volatile compared to industry and market?
1SAN volatility
1SAN Average Weekly Movement3.3%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.2%
10% most volatile stocks in IT Market7.8%
10% least volatile stocks in IT Market2.6%

Stable Share Price: 1SAN has not had significant price volatility in the past 3 months.

Volatility Over Time: 1SAN's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199486,088Paul Hudsonhttps://www.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
1SAN fundamental statistics
Market cap€114.57b
Earnings (TTM)€5.40b
Revenue (TTM)€46.03b

21.2x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1SAN income statement (TTM)
Revenue€46.03b
Cost of Revenue€14.22b
Gross Profit€31.82b
Other Expenses€26.42b
Earnings€5.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)4.32
Gross Margin69.12%
Net Profit Margin11.73%
Debt/Equity Ratio22.0%

How did 1SAN perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

87%

Payout Ratio

Does 1SAN pay a reliable dividends?

See 1SAN dividend history and benchmarks
When do you need to buy 1SAN by to receive an upcoming dividend?
Sanofi dividend dates
Ex Dividend DateMay 13 2024
Dividend Pay DateMay 15 2024
Days until Ex dividend45 days
Days until Dividend pay date47 days

Does 1SAN pay a reliable dividends?

See 1SAN dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.